N-[1-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]propan-2-yl]-2-(2-methylpropanoylamino)pyridine-4-carboxamide
C19H20ClF3N4O3 — CID 153311479
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]propan-2-yl]-2-(2-methylpropanoylamino)pyridine-4-carboxamide
N-[1-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]propan-2-yl]-2-(2-methylpropanoylamino)pyridine-4-carboxamide (PubChem CID 153311479) has the molecular formula C19H20ClF3N4O3 and a molecular weight of 444.84 g/mol. Its IUPAC name is N-[1-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]propan-2-yl]-2-(2-methylpropanoylamino)pyridine-4-carboxamide.
Molecular Properties
| Compound Name | N-[1-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]propan-2-yl]-2-(2-methylpropanoylamino)pyridine-4-carboxamide |
|---|---|
| PubChem CID | 153311479 |
| Molecular Formula | C19H20ClF3N4O3 |
| Molecular Weight | 444.84 g/mol |
| Exact Mass | 444.12 |
| IUPAC Name | N-[1-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]propan-2-yl]-2-(2-methylpropanoylamino)pyridine-4-carboxamide |
| SMILES | CC(COc1ncc(C(F)(F)F)cc1Cl)NC(=O)c1ccnc(NC(=O)C(C)C)c1 |
| InChI | InChI=1S/C19H20ClF3N4O3/c1-10(2)16(28)27-15-6-12(4-5-24-15)17(29)26-11(3)9-30-18-14(20)7-13(8-25-18)19(21,22)23/h4-8,10-11H,9H2,1-3H3,(H,26,29)(H,24,27,28) |
| InChIKey | PFJRXFOCIHXEGA-UHFFFAOYSA-N |
| XLogP | 3.94 |
| TPSA | 93.21 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 444.84 |
| LogP ≤ 5 | 3.94 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153311479 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.